| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 93301 | Null | 0.0260391472224207 | 0.022550174 |
| NSC 102225 | Null | 0.0267520285931239 | 0.29998274 |
| NSC 113423 | NSC 113423 | 0.0267520285931239 | 0.030567586 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0267520285931239 | 0.049042986 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.0267520285931239 | 0.083812025 |
| NSC 134459 | Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) | 0.0267520285931239 | 0.21179055 |
| NSC 13484 | Null | 0.0267520285931239 | 0.33171309 |
| NSC 168516 | Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- | 0.0267520285931239 | 0.24595014 |
| NSC 175493 | Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- | 0.0267520285931239 | 0.12900356 |
| NSC 21683 | Null | 0.0267520285931239 | 0.34125266 |